The Potential for Reducing Lynch Syndrome Cancer Risk with Nutritional Nrf2 Activators

References

• Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34(3):490–7. doi:10.1002/humu.22262
   PubMed Web of Science ®Google Scholar
• Lindor NM. Lynch syndrome 101 (years, that is). Am Soc Clin Oncol Educ Book [Internet]. 2014;101:27–32. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L606729856%5Cn 10.14694/EdBook_AM.2014.34.27%5Cn http://ak7rt6cb3z.search.serialssolutions.com?sid=EMBASE&issn=15488756&id=doi:10.14694%2FEdBook_AM.2014.34.27&atitle=
   Google Scholar
• ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TGW, et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. JCO. 2015;33(4):319–25. doi:10.1200/JCO.2014.57.8088
   PubMed Web of Science ®Google Scholar
• Bonadona V, Bonaïti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon Y-J, Caron O, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome. JAMA. 2011;305(22):2304–10. doi:10.1001/jama.2011.743
   PubMed Web of Science ®Google Scholar
• Botma A, Vasen HFA, Van Duijnhoven FJB, Kleibeuker JH, Nagengast FM, Kampman E. Dietary patterns and colorectal adenomas in lynch syndrome: the GEOLynch cohort study. Cancer. 2013;119(3):512–21. doi:10.1002/cncr.27726
   PubMed Web of Science ®Google Scholar
• van Duijnhoven FJB, Botma A, Winkels R, Nagengast FM, Vasen HFA, Kampman E. Do lifestyle factors influence colorectal cancer risk in lynch syndrome? Fam Cancer. 2013;12(2):285–93. [Internet]. Available from: http://link.springer.com/10.1007/s10689-013-9645-8
   PubMed Web of Science ®Google Scholar
• Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GNP, Kok FJ, Kampman E. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol. 2007;5(6):736–42. doi:10.1016/j.cgh.2007.02.019
   PubMed Web of Science ®Google Scholar
• Đermadi D, Valo S, Pussila M, Reyhani N, Sarantaus L, Lalowski M, Baumann M, Nyström M. Inherited cancer predisposition sensitizes colonic mucosa to address Western diet effects and putative cancer-predisposing changes on mouse proteome. J Nutr Biochem. 2014;25(11):1196–206. doi:10.1016/j.jnutbio.2014.06.002
   PubMed Web of Science ®Google Scholar
• Winter JM, Hu Y, Young GP, Kohonen-Corish MRJ, Le Leu RK. Role of red meat and resistant starch in promutagenic adduct formation, MGMT repair, thymic lymphoma and intestinal tumourigenesis in Msh2-deficient mice. J Nutrigenet Nutrigenomics. 2015;7(4-6):299–313. doi:10.1159/000381675
   Google Scholar
• Winkels RM, Botma A, Van Duijnhoven FJB, Nagengast FM, Kleibeuker JH, Vasen HFA, Kampman E. Smoking increases the risk for colorectal adenomas in patients with lynch syndrome. Gastroenterology. 2012;142(2):241–7. [Internet]. Available from: doi:10.1053/j.gastro.2011.10.033
   PubMed Web of Science ®Google Scholar
• Galland L. Diet and inflammation. Nutr Clin Pract. 2010;25(6):634–40. doi:10.1177/0884533610385703
   PubMed Web of Science ®Google Scholar
• Whalen KA, McCullough ML, Flanders WD, Hartman TJ, Judd S, Bostick RM. Paleolithic and mediterranean diet pattern scores are inversely associated with biomarkers of inflammation and oxidative balance in adults. J Nutr. 2016;146(6):1217–26. [Internet]. Available from: http://jn.nutrition.org/cgi/doi/10.3945/jn.115.224048
   PubMed Web of Science ®Google Scholar
• Slupphaug G, Kavli B, Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res - Fundam Mol Mech Mutagen. 2003;531(1–2):231–51. doi:10.1016/j.mrfmmm.2003.06.002
   PubMed Web of Science ®Google Scholar
• Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291(5507):1284–9. [Internet]. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1056154
   PubMed Web of Science ®Google Scholar
• Sameer AS, Nissar S, Fatima K. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis. Eur J Cancer Prev. 2014;23(4):246–57. doi:10.1097/CEJ.0000000000000019
   PubMed Web of Science ®Google Scholar
• Reyes GX, Schmidt TT, Kolodner RD, Hombauer H, Diego S, Jolla L. New insights into the mechanism of DNA mismatch repair. Chromosoma. 2015;124(4):443–62. doi:10.1007/s00412-015-0514-0
   PubMed Web of Science ®Google Scholar
• Martín-López JV, Fishel R. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. Fam Cancer. 2013;12(2):159–68. doi:10.1007/s10689-013-9635-x
   PubMed Web of Science ®Google Scholar
• Chang CL, Marra G, Chauhan DP, Ha HT, Chang DK, Ricciardiello L, Randolph A, Carethers JM, Boland CR. Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Physiol. 2002;283(1):C148–54. doi:10.1152/ajpcell.00422.2001
   PubMed Web of Science ®Google Scholar
• Bridge G, Rashid S, Martin SA. DNA mismatch repair and oxidative DNA damage: Implications for cancer biology and treatment. Cancers (Basel). 2014;6(3):1597–614. doi:10.3390/cancers6031597
   PubMed Web of Science ®Google Scholar
• Hsu GW, Ober M, Carell T, Beese LS. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature. 2004;431(7005):217–21. doi:10.1038/nature02908
   PubMed Web of Science ®Google Scholar
• Gupta RK, Patel AK, Shah N, Choudhary AK, Jha UK, Yadav UC, Gupta PK, Pakuwal U. Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev. 2014;15(11):4405–9. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24969860
   PubMedGoogle Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked?. Free Radic Biol Med. 2010;49(11):1603–16. [Internet]. Available from: doi:10.1016/j.freeradbiomed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Perse M. Oxidative stress in the pathogenesis of colorectal cancer: Cause or consequence? Biomed Res Int. 2013. doi:10.1155/2013/725710
   PubMed Web of Science ®Google Scholar
• Shalapour S, Karin M. Immunity, inflammation, and cancer an eternal fight between good and evil. J Clin Invest. 2015;125(9):3347–55. doi:10.1172/JCI80007
   PubMed Web of Science ®Google Scholar
• Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH. Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol. 2016;38:52–8. [Internet]. Available from: doi:10.1016/j.coi.2015.11.001
   PubMed Web of Science ®Google Scholar
• Landskron G, De La Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:1–19. doi:10.1155/2014/149185
   Web of Science ®Google Scholar
• Bardou M, Barkun AN, Martel M, Ceschi M, Gutzwiller F, Moch H. Obesity and colorectal cancer. Gut. 2013;62(6):933–47. [Internet]. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23481261&retmode=ref&cmd=prlinks%5Cnpapers2://publication/doi/10.1136/gutjnl-2013-304701%5Cn%3CGotoISI%3E://WOS:000291306900006
   PubMed Web of Science ®Google Scholar
• Mendonça FM, de Sousa FR, Barbosa AL, Martins SC, Araújo RL, Soares R, Abreu C. Metabolic syndrome and risk of cancer: which link. Metabolism. 2015;64(2):182–9. [Internet]. Available from: doi:10.1016/j.metabol.2014.10.008
   PubMed Web of Science ®Google Scholar
• Sara Achenza MI, Selmi C. Autoimmunity and Cancer. Asian Pacific J Cancer Prev. 2012;13(SUPPL.1):29–40.
   PubMedGoogle Scholar
• Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. WJG. 2014;20(29):9872–81. doi:10.3748/wjg.v20.i29.9872
   PubMed Web of Science ®Google Scholar
• Amir Aslani B, Ghobadi S. Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system. Life Sci. 2016;146:163–73. [Internet]. Available from: doi:10.1016/j.lfs.2016.01.014
   PubMed Web of Science ®Google Scholar
• Guerra-Araiza C, Álvarez-Mejía AL, Sánchez-Torres S, Farfan-García E, Mondragón-Lozano R, Pinto-Almazán R, Salgado-Ceballos H. Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases. Free Radic Res. 2013;47(6–7):451–62. doi:10.3109/10715762.2013.795649
   PubMed Web of Science ®Google Scholar
• Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015;97:55–74. [Internet]. Available from: doi:10.1016/j.ejmech.2015.04.040
   PubMed Web of Science ®Google Scholar
• Vomund S, Schäfer A, Parnham MJ, Brüne B. Von Knethen A. Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci. 2017;18(12):1–19.
   Web of Science ®Google Scholar
• Huang Y, Li W, Su Z, Kong A-N. The complexity of the Nrf2 pathway: Beyond the antioxidant response. Ageing Res Rev. 2015;22(2):134–9. [Internet]. Available from: 10.1016/j.arr.2011.12.005%5Cn 10.1016/j.freeradbiomed.2015.05.036
   Google Scholar
• Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39(4):199–218. [Internet]. Available from: doi:10.1016/j.tibs.2014.02.002
   PubMed Web of Science ®Google Scholar
• Turpaev KT. Keap1-Nrf2 signaling pathway: Mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles. Biochem Moscow. 2013;78(2):111–26. Available from: http://link.springer.com/10.1134/S0006297913020016
   PubMed Web of Science ®Google Scholar
• Jadeja RN, Upadhyay KK, Devkar RV, Khurana S. Naturally occurring Nrf2 activators: Potential in treatment of liver injury. Oxid Med Cell Longev. 2016;2016:1–13. doi:10.1155/2016/3453926
   Web of Science ®Google Scholar
• Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32(4-6):234–46. [Internet]. Available from: doi:10.1016/j.mam.2011.10.006
   PubMed Web of Science ®Google Scholar
• Holt SM, Scemama JL, Panayiotidis MI, Georgakilas AG. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells. Mutat Res - Genet Toxicol Environ Mutagen. 2009;674(1–2):123–30. doi:10.1016/j.mrgentox.2008.09.014
   Web of Science ®Google Scholar
• DeWeese TL, Shipman JM, Larrier NA, Buckley NM, Kidd LR, Groopman JD, Cutler RG, Te Riele H, Nelson WG. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc Natl Acad Sci. 1998;95(20):11915–20. [Internet]. Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.95.20.11915
   PubMed Web of Science ®Google Scholar
• Colussi C, Parlanti E, Degan P, Aquilina G, Barnes D, Macpherson P, Karran P, Crescenzi M, Dogliotti E, Bignami M, et al. The Mammalian Mismatch Repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr Biol. 2002;12(11):912–8. doi:10.1016/S0960-9822(02)00863-1
   PubMed Web of Science ®Google Scholar
• Ahadova A, Gallon R, Gebert J, Ballhausen A, Endris V, Kirchner M, Stenzinger A, Burn J, von Knebel Doeberitz M, Bläker H, et al. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer. 2018;143(1):139–50. doi:10.1002/ijc.31300
   PubMed Web of Science ®Google Scholar
• Felix R, Bodmer W, Fearnhead NS, van der Merwe L, Goldberg P, Ramesar RS. GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat Res - Fundam Mol Mech Mutagen. 2006;602(1–2):175–81. doi:10.1016/j.mrfmmm.2006.09.004
   PubMed Web of Science ®Google Scholar
• Reszka E, Jablonowski Z, Wieczorek E, Jablonska E, Krol MB, Gromadzinska J, Grzegorczyk A, Sosnowski M, Wasowicz W. Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients. J Cancer Res Clin Oncol. 2014;140(10):1723–31. doi:10.1007/s00432-014-1733-0
   PubMed Web of Science ®Google Scholar
• Kamiza AB, You J-F, Wang W-C, Tang R, Chang C-Y, Chien H-T, Lai C-H, Chiu L-L, Lo T-P, Hung K-Y, et al. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: a retrospective cohort study in Taiwan. Environ Mol Mutagen. 2018;59(1):69–78. [Internet]. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=prem&NEWS=N&AN=28714190 doi:10.1002/em.22113
   PubMed Web of Science ®Google Scholar
• Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, et al. Smoking and colorectal cancer in lynch syndrome: Results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010;16(4):1331–9. doi:10.1158/1078-0432.CCR-09-1877
   PubMed Web of Science ®Google Scholar
• Watson P, Ashwathnarayan R, Lynch HT, Roy HK. Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med. 2004;164(22):2429–31. Available from: http://archinte.jamanetwork.com/article.aspx?articleid=217777%5Cnpapers://5aecfcca-9729-4def-92fe-c46e5cd7cc81/Paper/p78548
   PubMedGoogle Scholar
• Brand RM, Jones DD, Lynch HT, Brand RE, Watson P, Ashwathnayaran R, et al. Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. WJG. 2006;12(28):4485–91. [Internet]. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4125634&tool=pmcentrez&rendertype=abstract doi:10.3748/wjg.v12.i28.4485
   PubMed Web of Science ®Google Scholar
• Botma A, Nagengast FM, Braem MGM, Hendriks JCM, Kleibeuker JH, Vasen HFA, Kampman E. Body mass index increases risk of colorectal adenomas in men with lynch syndrome: The GEOLynch cohort study. JCO. 2010;28(28):4346–53. doi:10.1200/JCO.2010.28.0453
   PubMed Web of Science ®Google Scholar
• Fardet A, Druesne-Pecollo N, Touvier M, Latino-Martel P. Do alcoholic beverages, obesity and other nutritional factors modify the risk of familial colorectal cancer? A systematic review. Crit Rev Oncol Hematol. 2017;119:94–112. [Internet]. Available from: doi:10.1016/j.critrevonc.2017.09.001
   PubMed Web of Science ®Google Scholar
• Mons U, Muscat JE, Modesto J, Richie JP, Brenner H. Effect of smoking reduction and cessation on the plasma levels of the oxidative stress biomarker glutathione - Post-hoc analysis of data from a smoking cessation trial. Free Radic Biol Med [Internet]. 2016;91:172–7. Available from: doi:10.1016/j.freeradbiomed.2015.12.018
   PubMed Web of Science ®Google Scholar
• Liu J, Liang Q, Frost-Pineda K, Muhammad-Kah R, Rimmer L, Roethig H, Mendes P, Sarkar M. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1760–9. doi:10.1158/1055-9965.EPI-10-0987
   PubMed Web of Science ®Google Scholar
• Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer—mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455–65. [Internet]. Available from: http://www.nature.com/doifinder/10.1038/nrendo.2014.94
   PubMed Web of Science ®Google Scholar
• Cox A, West N, Cripps A. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15. Vol. 3, doi:10.1016/S2213-8587(14)70134-2
   PubMed Web of Science ®Google Scholar
• Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):113–27.
   PubMed Web of Science ®Google Scholar
• Miguchi M, Hinoi T, Tanakaya K, Yamaguchi T, Furukawa Y, Yoshida T, Tamura K, Sugano K, Ishioka C, Matsubara N, et al. Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome : a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum. Surg Today. 2018;48(8):810–4. Available from: doi:10.1007/s00595-018-1654-7
   PubMed Web of Science ®Google Scholar
• Voskuil DW, Kampman E, Grubben MJAL, Kok FJ, Nagengast FM, Vasen HFA, van 't Veer P. Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. Eur J Cancer. 2002;38(17):2300–8. doi:10.1016/S0959-8049(02)00455-0
   PubMed Web of Science ®Google Scholar
• Pussila M, Sarantaus L, Bebek DD, Valo S, Reyhani N, Ollila S. Cancer-predicting gene expression changes in colonic mucosa of western diet fed Mlh1 +/- mice. PLoS One. 2013;8(10):1–12.
   Google Scholar
• Marie A, Neill O, Burrington CM, Gillaspie EA, Lynch DT, Horsman MJ. High-fat Western diet – induced obesity contributes to increased tumor growth in mouse models of human colon cancer. Nutr Res. 2016;36(12):1325–34. [Internet]. Available from: doi:10.1016/j.nutres.2016.10.005
   PubMed Web of Science ®Google Scholar
• Ringling RE, Gastecki ML, Woodford ML, Lum-Naihe KJ. Loss of Nlrp3 does not protect mice from western diet-induced adipose tissue inflammation and glucose intolerance. PLoS One. 2016;11 (9):1–17.
   Google Scholar
• Heinonen I, Rinne P, Ruohonen ST, Ruohonen S, Ahotupa M, Savontaus E. The effects of equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular endothelial function in mice. Acta Physiol. 2014;211(3):515–27. doi:10.1111/apha.12253
   PubMed Web of Science ®Google Scholar
• Naja F, Hwalla N, Itani L, Karam S, Mehio Sibai A, Nasreddine L. A Western dietary pattern is associated with overweight and obesity in a national sample of Lebanese adolescents (13-19 years): A cross-sectional study. Br J Nutr. 2015;114(11):1909–19. doi:10.1017/S0007114515003657
   PubMed Web of Science ®Google Scholar
• Senger DR, Li D, Jaminet SC, Cao S. Activation of the Nrf2 cell defense pathway by ancient foods: Disease prevention by important molecules and microbes lost from the modern western diet. PLoS One. 2016;11(2):e0148042–40. doi:10.1371/journal.pone.0148042
   PubMed Web of Science ®Google Scholar
• Myles IA. Fast food fever: reviewing the impacts of the western diet on immunity. Nutr J. 2014;13(1):1–17. doi:10.1186/1475-2891-13-61
   PubMed Web of Science ®Google Scholar
• Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of “western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014;14(1):404. doi:10.1007/s11882-013-0404-6
   PubMed Web of Science ®Google Scholar
• Hosseini B, Berthon BS, Wark P, Wood LG. Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: a systematic review and meta-analysis. Nutrients. 2017;9(4):341. doi:10.3390/nu9040341
   PubMed Web of Science ®Google Scholar
• Willcox DC, Scapagnini G, Willcox BJ. Healthy aging diets other than the Mediterranean: A focus on the Okinawan diet. Mech Ageing Dev. 2014;136–137:148–62. [Internet]. Available from: doi:10.1016/j.mad.2014.01.002
   PubMed Web of Science ®Google Scholar
• Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, et al. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018;143(9): 2250–2260.
   PubMed Web of Science ®Google Scholar
• Wang P, Li CG, Qi Z, Cui D, Ding S. Acute exercise stress promotes Ref1/Nrf2 signalling and increases mitochondrial antioxidant activity in skeletal muscle. Exp Physiol. 2016;101(3):410–20. doi:10.1113/EP085493
   PubMed Web of Science ®Google Scholar
• Abreu CC, Cardozo L, Mafra D. Could physical exercises modulate Nrf2-Keap1 pathway in chronic kidney disease? Med Hypotheses. 2015;84(1):44–6. [Internet]. Available from: doi:10.1016/j.mehy.2014.11.013
   PubMed Web of Science ®Google Scholar
• Li T, He S, Liu S, Kong Z, Wang J, Zhang Y. Effects of different exercise durations on Keap1-Nrf2-ARE pathway activation in mouse skeletal muscle. Free Radic Res. 2015;49(10):1269–74. doi:10.3109/10715762.2015.1066784
   PubMed Web of Science ®Google Scholar
• Korsager Larsen M, Matchkov VV. Hypertension and physical exercise: The role of oxidative stress. Medicina. 2016;52(1):19–27. [Internet]. Available from: doi:10.1016/j.medici.2016.01.005
   PubMedGoogle Scholar
• Wu SH, Shu XO, Chow W-H, Xiang Y-B, Zhang X, Li H-L, Cai Q, Milne G, Ji B-T, Cai H, et al. Nonexercise physical activity and inflammatory and oxidative stress markers in women. J Women’s Heal. 2014;23(2):159–67. [Internet]. Available from: http://online.liebertpub.com/doi/abs/10.1089/jwh.2013.4456
   PubMed Web of Science ®Google Scholar
• Kruk J, Czerniak U. Physical Activity and its Relation to Cancer Risk: Updating the Evidence. Asian Pac J Cancer Prev. 2013;14(7):3993–4003. doi:10.7314/APJCP.2013.14.7.3993
   PubMedGoogle Scholar
• Houghton CA, Fassett RG, Coombes JS. Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician’s expectation be matched by the reality. Oxid Med Cell Longev. 2016;2016:1–17. doi:10.1155/2016/7857186
   Web of Science ®Google Scholar
• Sun W, Liu X, Zhang H, Song Y, Li T, Liu X, Liu Y, Guo L, Wang F, Yang T, et al. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free Radic Biol Med. 2017;108:840–57. [Internet]. Available from: doi:10.1016/j.freeradbiomed.2017.04.365
   PubMed Web of Science ®Google Scholar
• Liu S, Tian L, Chai G, Wen B, Wang B. Targeting heme oxygenase-1 by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation. Food Funct. 2018;9(8):4184–93. Available from: http://xlink.rsc.org/?DOI=C8FO00650D doi:10.1039/C8FO00650D
   PubMed Web of Science ®Google Scholar
• Maurya AK, Vinayak M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention. Tumor Biol. 2015;36(11):8913–24. doi:10.1007/s13277-015-3634-5
   PubMed Web of Science ®Google Scholar
• Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008;269(2):315–25. doi:10.1016/j.canlet.2008.03.046
   PubMed Web of Science ®Google Scholar
• Sherif IO. The effect of natural antioxidants in cyclophosphamide-induced hepatotoxicity: Role of Nrf2/HO-1 pathway. Int Immunopharmacol. 2018;61:29–36. doi:10.1016/j.intimp.2018.05.007
   PubMed Web of Science ®Google Scholar
• Zhao CR, Gao ZH, Qu XJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol. 2010;34(5):523–33. [Internet]. Available from: doi:10.1016/j.canep.2010.06.012
   PubMed Web of Science ®Google Scholar
• Elshaer M, Chen Y, Wang XJ, Tang X. Resveratrol: An overview of its anti-cancer mechanisms. Life Sci. 2018;207:340–9. doi:10.1016/j.lfs.2018.06.028
   PubMed Web of Science ®Google Scholar
• Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetol. 2018;55(4):341–53. Available from: http://link.springer.com/10.1007/s00592-017-1098-3
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhao Y, Wang J, Wang X, Chen C, Yin D, Zhao F, Yin J, Guo M, Zhang L, et al. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation. Biochem Pharmacol. 2018;155:252–63. doi:10.1016/j.bcp.2018.07.006
   PubMed Web of Science ®Google Scholar
• Lu C, Xu W, Zheng S. Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells. Biomed Pharmacother. 2017;95:1–10. [Internet]. Available from: doi:10.1016/j.biopha.2017.08.037
   PubMed Web of Science ®Google Scholar
• Huang Y, Li W, Su Z, Kong AT, State T. The complexity of the Nrf2 pathway: Beyond the antioxidant response. J Nutritional Biochem. 2015;26(12):1401–13. doi:10.1016/j.jnutbio.2015.08.001
   PubMed Web of Science ®Google Scholar
• Sarkar B, Dhiman M, Mittal S, Mantha AK. Curcumin revitalizes Amyloid beta (25–35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2. Metab Brain Dis. 2017;32(6):2045–61. doi:10.1007/s11011-017-0093-2
   PubMed Web of Science ®Google Scholar
• Kang JS, Kim G-Y, Kim BW, Choi YH. Antioxidative effects of diallyl trisulfide on hydrogen peroxide- induced cytotoxicity through regulation of nuclear factor-E2-related factor-mediated thioredoxin reductase 1 expression in C2C12 skeletal muscle myoblast cells. Gen Physiol Biophys. 2017;36(5):521–9.
   PubMedGoogle Scholar
• Kim S, Lee H-G, Park S-A, Kundu JK, Keum Y-S, Cha Y-N, Na H-K, Surh Y-J. Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation. PLoS One. 2014;9(1):e85984. doi:10.1371/journal.pone.0085984
   PubMed Web of Science ®Google Scholar
• Miltonprabu S, Sumedha NC, Senthilraja P. Diallyl trisulfide, a garlic polysulfide protects against As-induced renal oxidative nephrotoxicity, apoptosis and inflammation in rats by activating the Nrf2/ARE signaling pathway. Int Immunopharmacol. 2017;50:107–20. [Internet]. Available from: doi:10.1016/j.intimp.2017.06.011
   PubMed Web of Science ®Google Scholar
• Puccinelli MT, Stan SD. Dietary bioactive diallyl trisulfide in cancer prevention and treatment. Int J Mol Sci. 2017;18(8):13–5.
   Web of Science ®Google Scholar
• Han X-D, Zhang Y-Y, Wang K-L, Huang Y-P, Yang Z-B, Liu Z. The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO2 -induced hepatotoxicity. Oncotarget. 2017;8(39):65302–12. [Internet]. Available from: http://www.oncotarget.com/fulltext/18582
   PubMedGoogle Scholar
• Mi Y, Zhang W, Tian H, Li R, Huang S, Li X, Qi G, Liu X. EGCG evokes Nrf2 nuclear translocation and dampens PTP1B expression to ameliorate metabolic misalignment under insulin resistance condition. Food Funct. 2018;9(3):1510–23. doi:10.1039/C7FO01554B
   PubMed Web of Science ®Google Scholar
• Pan C, Zhou S, Wu J, Liu L, Song Y, Li T, Ha L, Liu X, Wang F, Tian J, et al. NRF2 plays a critical role in both self and EGCG protection against diabetic testicular damage. Oxid Med Cell Longev. 2017;2017:1–13. doi:10.1155/2017/3172692
   Web of Science ®Google Scholar
• Antony ML, Singh SV. Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide. Indian J. Exp. Biol. 2011;49(11):805–16.
   PubMed Web of Science ®Google Scholar
• Ma HB, Huang S, Yin XR, Zhang Y, Di ZL. Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. WJG. 2014;20(1):193–203. doi:10.3748/wjg.v20.i1.193
   PubMed Web of Science ®Google Scholar
• Li W, Tian H, Li L, Li S, Yue W, Chen Z, Qi L, Hu W, Zhu Y, Hao B, et al. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo. Acta Biochim Biophys Sin. 2012;44(7):577–83. doi:10.1093/abbs/gms033
   Google Scholar
• Shin DY, Kim GY, Hwang HJ, Kim WJ, Choi YH. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways. Environ Toxicol Pharmacol. 2014;37(1):74–83. [Internet]. Available from: doi:10.1016/j.etap.2013.11.002
   PubMed Web of Science ®Google Scholar
• Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016;55(3):897–906. doi:10.1007/s00394-015-0922-1
   PubMed Web of Science ®Google Scholar
• Kodali RT, Eslick GD. Meta-analysis: Does garlic intake reduce risk of gastric cancer?. Nutr Cancer. 2015;67(1):1–11. doi:10.1080/01635581.2015.967873
   PubMed Web of Science ®Google Scholar
• Hu Y, McIntosh GH, Le Leu RK, Somashekar R, Meng XQ, Gopalsamy G, Bambaca L, McKinnon RA, Young GP. Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans. Br J Nutr. 2016;116(11):1901–11. doi:10.1017/S0007114516003937
   PubMed Web of Science ®Google Scholar
• Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66(2):1234–40. doi:10.1158/0008-5472.CAN-05-1145
   PubMed Web of Science ®Google Scholar
• Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, et al. A phase II randomized, double-blind, presurgical trial of polyphenon e in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers. Cancer Prev Res. 2017;10(5):298–307. doi:10.1158/1940-6207.CAPR-16-0167
   PubMed Web of Science ®Google Scholar
• Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Macis D, Mora S, Caldarella P, et al. A presurgical study of lecithin formulation of green tea extract in women with early breast cancer. Cancer Prev Res. 2017;10(6):363–9. doi:10.1158/1940-6207.CAPR-16-0298
   PubMed Web of Science ®Google Scholar
• Boots AW, Haenen G, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325–37. doi:10.1016/j.ejphar.2008.03.008
   PubMed Web of Science ®Google Scholar
• Zheng YZ, Deng G, Liang Q, Chen DF, Guo R, Lai RC. Antioxidant activity of quercetin and its glucosides from propolis: a theoretical study. Sci Rep. 2017;7(1):1–11. Available from: doi:10.1038/s41598-017-08024-8
   PubMedGoogle Scholar
• Aliaga C, Lissi E. a. Comparison of the free radical scavenger activities of quercetin and rutin — An experimental and theoretical study. Can J Chem. 2004;82(12):1668–73. doi:10.1139/v04-151
   Web of Science ®Google Scholar
• Sun Z, Huang Z, Zhang DD. Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One. 2009;4(8):e6588. doi:10.1371/journal.pone.0006588
   PubMed Web of Science ®Google Scholar
• Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ. Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev. 2008;17(3):553–62. doi:10.1158/1055-9965.EPI-07-2523
   PubMed Web of Science ®Google Scholar
• Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ. Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res. 2010;3(6):764–75. doi:10.1158/1940-6207.CAPR-09-0161
   PubMed Web of Science ®Google Scholar
• Cruz–Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006;4(8):1035–8. doi:10.1016/j.cgh.2006.03.020
   PubMed Web of Science ®Google Scholar
• Morrow DMP, Fitzsimmons PEE, Chopra M, McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin: Its effects on matrix metalloproteinase gene regulation. Mutat Res - Fundam Mol Mech Mutagen. 2001;480-481:269–76. doi:10.1016/S0027-5107(01)00184-1
   PubMed Web of Science ®Google Scholar
• Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ. Phase I clinical trial of the flavonoid tyrosine kinase quercetin : pharmacokinetics for in vivo. Clin. Cancer Res. 1996;2(4):659–68. (April):
   PubMed Web of Science ®Google Scholar
• Li YR, Li S, Lin CC. Effect of resveratrol and pterostilbene on aging and longevity. BioFactors. 2018;44(1):69–82. doi:10.1002/biof.1400
   PubMed Web of Science ®Google Scholar
• Marques BCAA, Trindade M, Aquino JCF, Cunha AR, Gismondi RO, Neves MF, Oigman W. Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction. Clin Exp Hypertens. 2018;40(3):218–23. [Internet]. Available from: https://www.tandfonline.com/doi/full/10.1080/10641963.2017.1288741
   PubMed Web of Science ®Google Scholar
• Pan MH, Wu JC, Ho CT, Lai CS. Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene. BioFactors. 2018;44(1):50–60. doi:10.1002/biof.1409
   PubMed Web of Science ®Google Scholar
• Peñalver P, Belmonte-Reche E, Adán N, Caro M, Mateos-Martín ML, Delgado M, González-Rey E, Morales JC. Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases. Eur J Med Chem. 2018;146:123–38. doi:10.1016/j.ejmech.2018.01.037
   PubMed Web of Science ®Google Scholar
• Espinoza JL, Trung LQ, Inaoka PT, Yamada K, An DT, Mizuno S, Nakao S, Takami A. The repeated administration of resveratrol has measurable effects on circulating T-cell subsets in humans. Oxid Med Cell Longev. 2017;2017:1–10. doi:10.1155/2017/6781872
   Web of Science ®Google Scholar
• Khanduja KL, Bhardwaj A. Stable free radical and antiperoxide properties of resveratrol compared in vitro with some other bioflavoids. Indian J Biochem Biophys. 2003;40:416–22.
   PubMed Web of Science ®Google Scholar
• Patel KR, Brown VA, Jones DJL, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70(19):7392–9. doi:10.1158/0008-5472.CAN-10-2027
   PubMed Web of Science ®Google Scholar
• Holcombe RF, Nguyen Martinez Stamos Moyer Planutis, et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009;1:25.
   PubMedGoogle Scholar
• Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res. 2011;4(9):1419–25. doi:10.1158/1940-6207.CAPR-11-0148
   PubMed Web of Science ®Google Scholar
• Mantzorou M, Pavlidou E, Vasios G, Tsagalioti E, Giaginis C. Effects of curcumin consumption on human chronic diseases: a narrative review of the most recent clinical data. Phyther Res. 2018;32(6):957–75. doi:10.1002/ptr.6037
   PubMed Web of Science ®Google Scholar
• Barzegar A. The role of electron-transfer and H-atom donation on the superb antioxidant activity and free radical reaction of curcumin. Food Chem. 2012;135(3):1369–76. [Internet]. Available from: doi:10.1016/j.foodchem.2012.05.070
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Bebawy M, Luk F, Mason R, Rohanizadeh R. Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century. Curr Neuropharmacol. 2013;11(4):338–78. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-159X&volume=11&issue=4&spage=338 doi:10.2174/1570159X11311040002
   PubMed Web of Science ®Google Scholar
• Deck LM, Hunsaker LA, Vander Jagt TA, Whalen LJ, Royer RE, Vander Jagt DL. Vander Jagt DL. Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin. Eur J Med Chem. 2018;143:854–65. [Internet]. Available from:doi:10.1016/j.ejmech.2017.11.048
   PubMed Web of Science ®Google Scholar
• He Z-Y, Shi C-B, Wen H, Li F-L, Wang B-L, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011;29(3):208–13. [Internet]. Available from: http://www.tandfonline.com/doi/full/10.3109/07357907.2010.550592
   PubMed Web of Science ®Google Scholar
• Garcea G, Berry DP, Jones DJL, Singh R, Dennison AR, Farmer PB. Consumption of the putative chemopreventive agent curcumin by cancer patients : assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Prev Biomarkers. 2005;14: 120-125.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Mukhtar H. Antioxidants meet molecular targets for cancer prevention and therapeutics. Antioxid Redox Signal. 2013;19(2):85–8. [Internet]. Available from: http://online.liebertpub.com/doi/abs/10.1089/ars.2013.5299
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin : biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847–54. doi:10.1158/1078-0432.CCR-04-0744
   PubMed Web of Science ®Google Scholar
• Martins T, Colaço B, Venâncio C, Pires MJ, Oliveira PA, Rosa E, Antunes LM. Potential effects of sulforaphane to fight obesity. J Sci Food Agric. 2018;98(8):2837–44. doi:10.1002/jsfa.8898
   PubMed Web of Science ®Google Scholar
• Malaguti M, Angeloni C, Hrelia S. Nutraceutical bioactive compounds promote healthspan counteracting cardiovascular diseases. J Am Coll Nutr. 2015;34(sup1):22–7. doi:10.1080/07315724.2015.1080107
   PubMed Web of Science ®Google Scholar
• Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AME, Ortori CA, Barrett DA, et al. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008;3(7):e2568. doi:10.1371/journal.pone.0002568
   PubMed Web of Science ®Google Scholar
• Egner PA, Chen J-G, Zarth AT, Ng DK, Wang J-B, Kensler KH, Jacobson LP, Munoz A, Johnson JL, Groopman JD, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prev Res. 2014;7(8):813–23. doi:10.1158/1940-6207.CAPR-14-0103
   PubMed Web of Science ®Google Scholar
• Axelsson A, Tubbs E, Mecham B, Chacko S, Nenonen H, Tang Y, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med. 2017;9(394):4477. [Internet]. Available from: http://0-stm.sciencemag.org.wam.leeds.ac.uk/content/scitransmed/9/394/eaah4477.full.pdf%0A http://0-ovidsp.ovid.com.wam.leeds.ac.uk/ovidweb.cgi?T=JS&PAGE=reference&D=emexb&NEWS=N&AN=616869431
   Web of Science ®Google Scholar
• Kikuchi M, Ushida Y, Shiozawa H, Umeda R, Tsuruya K, Aoki Y, et al. Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects. WJG. 2015;21(43):12457–67. doi:10.3748/wjg.v21.i43.12457
   PubMed Web of Science ®Google Scholar
• Cipolla BG, Mandron E, Lefort JM, Coadou Y, Della Negra E, Corbel L, Le Scodan R, Azzouzi AR, Mottet N. Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy. Cancer Prev Res. 2015;8(8):712–9. doi:10.1158/1940-6207.CAPR-14-0459
   PubMed Web of Science ®Google Scholar
• Bauman JE, Zang Y, Sen M, Li C, Wang L, Egner PA, Fahey JW, Normolle DP, Grandis JR, Kensler TW, et al. Prevention of carcinogen-induced oral cancer by sulforaphane. Cancer Prev Res. 2016;9(7):547–57. doi:10.1158/1940-6207.CAPR-15-0290
   PubMed Web of Science ®Google Scholar